Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing medical applications of CBD
3.2.1.2 Increasing product adoption and utilization owing to government approvals
3.2.1.3 Changing regulatory landscape for approval of CBD products across region
3.2.1.4 Increasing sales of CBD products in retail stores
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects associated with CBD oil
3.2.2.2 Counterfeit and synthetic products available in the market
3.2.2.3 High cost of CBD products
3.2.2.4 Complex prescription process
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Future market trends
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Source, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Marijuana
5.3 Hemp
Chapter 6 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Oil
6.2.1 Full-spectrum CBD oil
6.2.2 Broad-spectrum CBD oil
6.3 Topicals
6.3.1 Transdermal patches
6.3.2 Creams and roll-on
6.4 Oral
6.4.1 Tablet
6.4.2 Capsules
6.4.3 Tinctures
6.5 CBD inhalers
6.6 Suppository
6.7 Isolates
6.8 Vape oil
6.9 Other products
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Anxiety/ stress
7.3 Sleep/insomnia
7.4 Chronic pain
7.5 Migraines
7.6 Skin care
7.7 Seizures
7.8 Joint pain & inflammation
7.9 Other applications
Chapter 8 Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Oral
8.3 Topical
8.4 Inhalation
8.5 Transdermal patches
8.6 Rectal
8.7 Sublingual
Chapter 9 Market Estimates and Forecast, By Distribution Channel, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Online
9.3 Offline
9.3.1 Hospital pharmacy
9.3.2 Retail stores
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East and Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Aurora Cannabis
11.2 Charlotte's Web
11.3 Canopy Growth Corporation
11.4 CV Sciences, Inc.
11.5 Endoca
11.6 Elixinol
11.7 Folium Biosciencesilray
11.8 Gaia Herbs, LLC,
11.9 GW Pharmaceuticals
11.10 Isodiol International Inc
11.11 KOI CBD
11.12 Medical Marijuana, Inc.
11.13 Medterra
11.14 NuLeaf Naturals, LLC,
11.15 Tterrapharma
11.16 Tilray
11.17 Vapen CBD
